|
Carbotherapy-20 is classified as a Medicinal gas. It is used to induce vasodilation in the central nervous system. Carbotherapy-20 complies with the European Pharmacopoeia.
Composition: CO2: 20%; O2: QS
Therapeutic Indication: Cerebral stimulation
Product Availability: Spain |
|
Carbotherapy-4.5 is classified as a Medicinal gas. It is used to induce vasodilation in the central nervous system. Carbotherapy-4.5 complies with the European Pharmacopoeia.
Composition: CO2: 20%; O2: QS
Therapeutic Indication: Cerebral stimulation
Product Availability: Spain |
CEC-1 |
CEC-1 is classified as Medicinal gas. It is used to treat sudden deafness and to stimulate the central respiratory drive. CEC-1 complies with the European Pharmacopoeia.
Composition: CO2: 5%; Oxygen: QS
Therapeutic Indication: Treatment of sudden deafness and to stimulate central respiratory drive.
Product Availability: Belgium, Czech Republic, France, Netherlands
| |
|
CEC-1 is classified as Medicinal gas. It is used to treat sudden deafness and to stimulate the central respiratory drive. CEC-1 complies with the European Pharmacopoeia.
Composition: CO2: 5%; Oxygen: QS
Therapeutic Indication: Treatment of sudden deafness and to stimulate central respiratory drive.
Product Availability: Belgium, Czech Republic, France, Netherlands
|
|
CEC-2 is classified as Medicinal gas. It is used to treat sudden deafness and to stimulate the central respiratory drive. CEC-2 complies with the European Pharmacopoeia.
Composition: CO2: 7%; Oxygen: QS
Therapeutic Indication: Treatment of sudden deafness and to stimulate the central respiratory drive.
Product Availability: France |